Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 6
2006 9
2007 5
2008 3
2009 3
2010 4
2011 3
2012 1
2013 1
2014 2
2015 6
2016 11
2017 9
2018 4
2019 3
2020 2
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Freiberg F, Michels S. Freiberg F, et al. Among authors: michels s. Retina. 2017 Sep;37(9):e107-e108. doi: 10.1097/IAE.0000000000001808. Retina. 2017. PMID: 28820852 No abstract available.
Nonneovascular Age-Related Macular Degeneration.
Michels S, Garhöfer G. Michels S, et al. Dev Ophthalmol. 2016;55:112-24. doi: 10.1159/000434695. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26502209 Review.
Assistive Device for Efficient Intravitreal Injections.
Ullrich F, Michels S, Lehmann D, Pieters RS, Becker M, Nelson BJ. Ullrich F, et al. Among authors: michels s. Ophthalmic Surg Lasers Imaging Retina. 2016 Aug 1;47(8):752-62. doi: 10.3928/23258160-20160808-09. Ophthalmic Surg Lasers Imaging Retina. 2016. PMID: 27548453 Review.
[Age-related macular degeneration (AMD)].
Michels S, Kurz-Levin M. Michels S, et al. Ther Umsch. 2009 Mar;66(3):189-95. doi: 10.1024/0040-5930.66.3.189. Ther Umsch. 2009. PMID: 19266466 Review. German.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Among authors: michels s. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
72 results